Sfoglia per Autore
Postprandial cholesterol metabolism: a clue to the impact of TM6SF2 rs58542926 variant on liver and cardiovascular disease in NAFLD?
2016-01-01 Gambino, R.; Cassader, M.; Saba, F.; Pinach, S.; Alemanno, N.; Musso, G.
Different Serum Free Fatty Acid Profiles in NAFLD Subjects and Healthy Controls after Oral Fat Load
2016-01-01 Gambino, Roberto; Bugianesi, Elisabetta; Rosso, Chiara; Mezzabotta, Lavinia; Pinach, Silvia; Alemanno, Natalina; Saba, Francesca; Cassader, Maurizio
After oral fat load NAFLD subjects and healthy controls show different serum free fatty acid trends.
2014-01-01 R. Gambino; E. Bugianesi; C. Rosso; L. Mezzabotta; S. Pinach; N. Alemanno; F. Saba; M. Cassader
Serum free fatty acid composition is associated with different degrees of fibrosis.
2014-01-01 R. Gambino; N. Alemanno; S. Pinach; F. Saba; L. Mezzabotta; C. Rosso; E. Vanni; E. Bugianesi; M. Cassader
SREBF-1C polymorphism affects postprandial lipid metabolism in NAFLD subjects.
2013-01-01 R. Gambino; S. Bo; G. Musso; S. Pinach; N. Alemanno; V. Nuvoli; F. Saba; M. Cassader
INCIDENCE AND SEVERITY OF NONALCOHOLIC FATTY LIVER DISEASE ASSOCIATED WITH IMPAIRED LIPID AND GLUCOSE METABOLISM ARE PREDICTED BY SREBF POLYMORPHISM.
2012-01-01 R. Gambino; S. Bo; G. Musso; S. Pinach; N. Alemanno; M. Potenza; F. Saba; M. Cassader.
LECTIN-LIKE OXIDIZED LDL RECEPTOR-1 (LOX-1) POLYMORPHISM IS INDEPENDENTLY ASSOCIATED WITH LIVER HISTOLOGY IN NASH.
2011-01-01 Roberto Gambino; Giovanni Musso; Maurizio Cassader; Francesca Saba; Natalina Alemanno; Matteo Potenza; Simona Bo
GLUCOSE HOMEOSTASIS AND POSTPRANDIAL LIPOPROTEIN METABOLISM IN NONALCOHOLIC STEATOHEPATITIS (NASH) ARE AFFECTED BY LECTIN-LIKE OXIDIZED LDL RECEPTOR-1 (LOX-1) POLYMORPHISM.
2011-01-01 Roberto Gambino; Giovanni Musso; Maurizio Cassader; Francesca Saba; Natalina Alemanno; Matteo Potenza; Simona Bo.
LOXIN POLYMORPHISM IS ASSOCIATED WITH INCREASED RESISTIN LEVELS AND WITH OXIDATIVE STATUS.
2010-01-01 R. Gambino; S. Bo; N. Alemanno; G. Pagano; P. Cavallo-Perin; M. Cassader.
Evaluation of TCF7L2 polymorphism as a new tool in the prediction of impaired fasting glucose and diabetes.
2010-01-01 R.Gambino; S. Bo; G. Pagano; N.Alemanno; M. Cassader
IS THE DETERMINATION OF TCF7L2 POLYMORPHISM A USEFUL MARKER IN THE PREDICTION OF IMPAIRED GLUCOSE METABOLISM?
2010-01-01 R.Gambino; S. Bo; N.Alemanno; M. Cassader; P. Cavallo-Perin; G.Pagano.
La determinazione del polimorfismo di TCF7L2 può essere utile nella predizione dell'alterato metabolismo glucidico?
2010-01-01 Gambino R; Bo S; Alemanno N; Gentile L; Cassader M; Pagano G.
Potential prognostic value of TCL7L2 polymorphism in the prediction of impaired fasting glucose and diabetes.
2009-01-01 R.Gambino; S. Bo; G. Pagano; N.Alemanno; L. Gentile; M. Cassader.
Phytosterol-Enriched Yogurt Increases LDL Affinity and Reduces CD36 Expression in Polygenic Hypercholesterolemia
2009-01-01 Ruiu G; Pinach S; Veglia F; Gambino R; Marena S; Uberti B; Alemanno N; Burt D; Pagano G; Cassader M.
A reduced postprandial total antioxidant activity is associated with liver injury and vitamin E intake in nonalcoholic steatohepatitis.
2008-01-01 Gambino R; Musso G; Alemanno N; Uberti B; Cassader M.
Microsomal triglyceride transfer protein 493-T variant is associated with resistin levels and C-reactive protein
2007-01-01 R. GAMBINO; S. BO; G. MUSSO; B. UBERTI; N. ALEMANNO; F. GHIONE; S. GUIDI; E. TIOZZO; V. CHIUSANO; L. GENTILE; M. DURAZZO; G. PAGANO; M. CASSADER
Association of microsomal triglyceride transfer protein 493-T variant with resistin levels and c-reactive protein.
2006-01-01 Gambino R; Bo S; Uberti B; Alemanno N; Ghione F; Guidi S; Durazzo M; Pagano G; Cassader M
Influence of cyclosporine on low-density lipoprotein uptake in human lymphocytes
2005-01-01 RUIU G; PINACH S; GAMBINO R; UBERTI B; ALEMANNO N; PAGANO G; CASSADER M
Poor glycemic control does not influence the oxidizability of circulating LDL in type 2 diabetic patients.
2004-01-01 Roberto Gambino; Gianluca Ruiu; Natalina Alemanno; Elisabetta Pisu; Gianfranco Pagano; Maurizio Cassader.
In vivo oxidizability of LDL in type 2 diabetic patients in good and poor glycemic control
2004-01-01 R. GAMBINO; B. UBERTI; N. ALEMANNO; E. PISU; G. PAGANO; M. CASSADER
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile